Role of local anesthetics on both cholinergic and serotonergic ionotropic receptors

Neuroscience and Biobehavioral Reviews

Volumn 23, Issue 6, 1999, Pages 817-843

  Arias, Hugo Rubén ^a  

^a Instituto de Investigaciones Bioquimicas Bahia Blanca   (Argentina)

Author keywords

5 Hydroxytryptamine type 3 receptor; Competitive antagonists; Local anesthetics; Localization of binding sites; Mechanisms of action; Nicotinic acetylcholine receptors; Noncompetitive inhibitors

Indexed keywords

ADIPHENINE; BENZOCAINE; CHOLINERGIC RECEPTOR; CINCHOCAINE; COCAINE; HISTRIONICOTOXIN; ION CHANNEL; IONOTROPIC RECEPTOR; LIDOCAINE; LIDOCAINE ETHOBROMIDE; LOCAL ANESTHETIC AGENT; MEPACRINE; N [(2,6 DIMETHYLPHENYL)CARBAMOYLMETHYL]TRIMETHYLAMMONIUM; PIPEROCAINE; PRILOCAINE; PROADIFEN; PROCAINAMIDE; PROCAINE; QUINISOCAINE; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; SEROTONIN 3 RECEPTOR; SEROTONIN RECEPTOR; TETRACAINE; TRIMETHISOQUIN; UNCLASSIFIED DRUG;

ALLOSTERISM; BINDING SITE; DESENSITIZATION; DRUG MECHANISM; DRUG RECEPTOR BINDING; FROG; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STRUCTURE ACTIVITY RELATION; SYNAPTIC TRANSMISSION;

EID: 0032886030     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(99)00020-2     Document Type: Article

References (151)

1. Catterall W., Mackie K. Local anesthetics. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W. Goodman & Gilman's the pharmacological basis of therapeutics. 9 :1996;331-347 McGraw-Hill, New York.
2. Butterworth J.F., Strichartz G.R. Molecular mechanisms of local anesthesia: a review. Anesthesiology. 72:1990;711-734.
3. Catterall W.A. Cellular and molecular biology of voltage-gated sodium channels. Physiol Rev. 72:1992;S15-S48.
4. Talbot M.J., Sayer R.J. Intracellular QX-314 inhibits calcium currents in hippocampal CA1 pyramidal neurons. J Neurophysiol. 76:1996;2120-2124.
5. Urban B.J. Clinical observations suggesting a changing site of action during induction and recession of spinal and epidural anesthesia. Anesthesiology. 70:1973;851-858.
6. 2+. Anesthesiology. 82:1995;166-173.
7. Cuevas J., Adams D.J. Local anaesthetic blockade of neuronal nicotinic Ach receptor-channels in rat parasympathetic ganglion cells. Br J Pharmacol. 111:1994;663-672.
8. 14C-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastome cells. Naunyn-Schmiedeberg's Arch Pharmacol. 347:1993;125-132.
9. Fan P., Oz M., Zhang L., Weight F.F. Effect of cocaine on the 5-HT3 receptor-mediated current in Xenopus oocytes. Neuropsychopharmacology. 10:(Suppl./Part 3):1994;31.
10. Fan P., Weight F.F. Procaine impairs the function of the 5-HT3 receptor-ion channel complex in rat sensory ganglion neurons. Neuropsychopharmacology. 33:1994;1573-1579.
11. Sepúlveda M.I., Baker J., Lummis S.C.R. Chlorpromazine and QX222 block 5-HT3 receptors in N1E-115 neuroblastoma cells. Neuropharmacology. 33:1994;493-499.
12. Parker R.M.C., Bentley K.R., Barnes N.M. Allosteric modulation of 5-HT3 receptors: focus on alcohol and anaesthetic agents. Trends Pharmacol Sci. 17:1996;95-99.
13. Cohen M.L. 5-HT3 receptors in periphery. Hamon M. Central and peripheral 5-HT3 receptors. 1992;20-32 Academic Press, London.
14. Greenshaw A.J. Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential. Trends Pharmacol Sci. 14:1993;265-270.
15. Ritchie J.M., Greene N.M. Local anesthetics. Gilman A.G., Rall T.W., Nies A.S., Taylor P. The pharmacological basis of therapeutics. 1991;311-331 Pergamon Press, New York.
16. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Prog Neurobiol. 53:1997;199-237.
17. McGehee D.S., Role L.W. Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Ann Rev Physiol. 57:1995;521-546.
18. Mileo A.M., Monaco L., Palma E., Grassi F., Miledi R., Eusebi F. Two forms of acetylcholine receptor γ subunit in mouse muscle. Proc Natl Acad Sci USA. 92:1995;2686-2690.
19. Mihovilovic M., Mai Y., Herbstreith M., Rubboli F., Tarroni P., Clementi F., Roses A.D. Splicing of an antisense Alu sequence generates a coding sequence variant for the α3 subunit of a neuronal nicotinic receptor. Biochem Biophys Res Commun. 197:1993;137-144.
20. Galzi J.L., Changeux J.P. Neuronal nicotinic receptors: molecular organization and regulations. Neuropharmacology. 34:1995;563-582.
21. Keyser K.T., Britto L.R.G., Schoepfer R., Whiting P., Cooper J., Conroy W., Borozozowska-Prechtl A., Karten H.J., Lindstrom J. Three subtypes of α-bungarotoxin-sensitive nicotinic acetylcholine receptors are expressed in chick retina. J Neurosci. 13:1993;442-454.
22. Palma E., Bertrand S., Binzoni T., Bertrand D. Neuronal nicotinic α7 receptor expressed in Xenopus oocytes present five putative binding sites for methyllycaconitine. J Physiol. 491.1:1996;151-161.
23. Machold J., Utkin Y.N., Kirsch D., Kaufmann R., Tsetlin V.I., Hucho F. Photolabeling reveals the proximity of the α-neurotoxin binding site to the M2 helix of the ion channel in the nicotinic acetylcholine receptor. Proc Natl Acad Sci USA. 92:1995;7282-7286.
24. Arias H.R. Topology of ligand binding sites on the nicotinic acetylcholine receptor. Brain Res Rev. 25:1997;133-191.
25. Hucho F., Tsetlin V.I., Machold J. The emerging three-dimensional structure of a receptor: the nicotinic acetylcholine receptor. Eur J Biochem. 239:1996;539-557.
26. Boess F.G., Martin I.L. Molecular biology of 5-HT receptors. Neuropharmacology. 33:1994;275-317.
27. Sanders-Bush E., Mayer S.E. 5-Hydroxytryptamine (serotonin) receptor agonists and antagonists. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W. Goodman & Gilman's the pharmacological basis of therapeutics. 1996;249-263 McGraw-Hill, New York.
28. Niemeyer M.I., Lummis S.C.R. Diffrerent efficacy of specific agonists at 5-HT3 receptor splice variants: the role of the extra six amino acid segment. Br J Pharmacol. 123:1998;661-666.
29. 3 receptor. J Neurochem. 64:1995;1401-1405.
30. Eiselé J.L., Bertrand S., Galzi J.L., Devillers-Thiéry A., Changeux J.P., Bertrand D. Chimaeric nicotinic-serotoninergic receptor combines distinct ligand binding and channel specificities. Nature. 366:1993;479-483.
31. Galzi J.L., Devillers-Thiéry A., Hussy N., Bertrand S., Changeux J.P. Mutations in the ion channel domain of a neuronal nicotinic receptor convert ion selectivity from cationic to anionic. Nature. 359:1992;500-505.
32. Fletcher S., Lindstrom J.M., McKernan R.M., Barnes N.M. Evidence that porcine native 5-HT3 receptors do not contain nicotinic acetylcholine recceptor subunits. Neuropharmacology. 37:1998;397-399.
33. Alburquerque E.X., Alkondon M., Pereira E.F.R., Castro N.G., Schrattenholz A., Barbosa C.T.F., Bonfante-Cabarcas R., Aracava Y., Eisenberg H.M., Maelicke A. Properties of neuronal nicotinic actylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther. 280:1997;1117-1136.
34. Peters J.A., Hales T.G., Lambert J.J. Divalent cations modulates 5-HT3 receptor-induced currents in N1E-115 neuroblastoma cells. Eur J Pharmacol. 151:1988;491-495.
35. Pugh P.C., Berg D.K. Neuronal acetylcholine receptors that bind alpha-bungarotoxin mediate neurite retraction in a calcium-dependent manner. J Neurosci. 14:1994;889-896.
36. Messi M.L., Renganathan M., Grigorenko E., Delbono O. Activation of α7 nicotinic acetylcholine receptor promotes survival of spinal cord motoneurons. FEBS Lett. 411:1997;32-38.
37. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
38. Peters J.A., Malone H.M., Lambert J.J. Recent advances in the electrophysilogical characterization of of 5-HT3 receptors. Trends Pharmacol Sci. 13:1992;391-397.
39. Zifa E., Fillion G. 5-Hydroxytryptamine receptors. Pharmacol Rev. 44:1992;401-458.
40. de Paula E., Schreier S. Molecular and physicochemical aspects of local anesthetic-membrane interaction. Brazilian J Med Biol Res. 29:1996;877-894.
41. Koblin D.D., Lester H. Voltage-dependent and voltage-independent blockade of acetylcholine receptors by local anesthetics. Mol Pharmacol. 15:1979;559-580.
42. Adams P.R. Voltage jump analysis of procaine action at frog end-plate. J Physiol. 268:1977;291-318.
43. Horn R., Brodwick M.S., Dickey W.D. Asymmetry of the acetylcholine channel revealed by quaternary anesthetics. Science. 210:1980;205-207.
44. Katz B., Miledi R. The effect of procaine on the action of acetylcholine at the neuromuscular junction. J Physiol. 249:1975;269-284.
45. Ruff R.L. The kinetics of local anesthetic blockage of end-plate channels. Biophys J. 37:1982;625-631.
46. Charnet P., Labarca C., Leonard R.J., Vogelaar N.J., Czyzyk L., Gouin A., Davidson N., Lester H.A. An open channel blocker interacts with adjacent turns of α-helices in the nicotinic acetylcholine receptor. Neuron. 2:1990;87-95.
47. Charnet P., Labarca C., Lester H.A. Structure of the γ-less nicotinic acetylcholine receptor: learning from omission. Mol Pharmacol. 41:1992;708-717.
48. Dilger J.P., Vidal A.M. Cooperative interactions between general anesthetics and QX-222 within the pore of the acetylcholine receptor ion channel. Mol Pharmacol. 45:1994;169-175.
49. Leonard R.J., Labarca C.G., Charnet P., Davidson N., Lester H.A. Evidence that the M2 membrane-spanning region lines the ion channel pore of the nicotinic receptor. Science. 242:1988;1578-1581.
50. Neher E., Steinbach J.H. Local anaesthetic transiently block current through single acetylcholine receptor channel. J Physiol. 277:1978;153-176.
51. Ogden D.C., Siegelbaum S.A., Colquhoun D. Block of acetylcholine-activated ion channels by an uncharged local anesthetic. Nature. 289:1981;596-598.
52. Charnet P., Labarca C., Cohen B.N., Davidson N., Lester H.A., Pilar G. Pharmacological and kinetic properties of α4β2 neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Physiol. 450:1992;375-394.
53. Revah F., Bertrand D., Galzi J.L., Devillers-Thiéry A., Mulle C., Hussy N., Bertrand S., Ballivet M., Changeux J.P. Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature. 353:1991;846-849.
54. Forman S.A., Miller K.W. Procaine rapidly inactivates acetylcholine receptors from Torpedo and competes with agonists for inhibition sites. Biochemistry. 28:1989;1678-1685.
55. Arias H.R. Agonist self-inhibitory binding site of the nicotinic acetylcholine receptor. J Neurosci Res. 44:1996;97-105.
56. Arias H.R. Binding sites for exogenous and endogenous non-competitive inhibitors of the nicotinic acetylcholine receptor. Biochim Biophys Acta. 1376:1998;173-220.
57. Lester H.A. The permeation pathway of neurotransmitter-gated ion channels. Ann Rev Biohpys Biomol Str. 21:1992;267-292.
58. Neher E. The charge carried by single-channel currents of rat cultured muscle cells in the presence of local anesthetics. J Physiol. 339:1983;663-678.
59. Leonard R.J., Charnet P., Labarca C., Vogelaar N.J., Czyzyk L., Gouin A., Davidson N., Lester H.A. Reverse pharmacology of the nicotinic acetylcholine receptor: mapping the local anesthetic binding site. Ann NY Acad Sci. 625:1991;588-599.
60. Hess G.P., Niu L., Weiboldt R. Determination of the chemical mechanism of neurotransmitter receptor-mediated reactions by rapid chemical kinetic methods. Ann NY Acad Sci. 757:1995;23-39.
61. Niu L., Hess G.P. An acetylcholine receptor regulatory site in BC3H-1 cells: characterized by laser-pulse photolysis in the microsecond-to-millisecond time region. Biochemistry. 32:1993;3831-3835.
62. Niu L., Abood L.G., Hess G.P. Cocaine: mechanism of inhibition of a muscle acetylcholine receptor studied by laser-pulse photolysis technique. Proc Natl Acad Sci USA. 92:1995;12 008-12 012.
63. Karpen J.W., Aoshima H., Abood L.G., Hess G.P. Cocaine and phencyclidine inhibition of the acetylcholine receptor: Analysis of the mechanisms of action based on measurements of ion flux in the millisecond-to-minute time region. Proc Natl Acad Sci USA. 79:1982;2509-2513.
64. Karpen J.W., Hess G.P. Cocaine, phencyclidine, and procaine inhibition of the acetylcholine receptor: Characterizatin of the binding site by stopped-flow measurements of receptor-controlled ion flux in membrane vesicles. Biochemistry. 25:1986;17 777-17 785.
65. Swanson K.L., Alburquerque E.X. Nicotinic acetylcholine receptor ion channel blockade by cocaine. The mechanism of synaptic action. J Pharmacol Exp Ther. 243:1987;1202-1210.
66. Lerner-Marmarosh N., Carroll F.I., Abood L.G. Antagonism of nicotine's action by cocaine analogues. Life Sci. 56:1995;67-70.
67. Lukas R.J., Bennett E.L. Effects of local anesthetics on cholinergic agonist binding affinity of central nervous system α-bungarotoxin receptors. FEBS Lett. 108:1979;356-358.
68. Heidmann T., Changeux J-P. Fast kinetic studies on the allosteric interactions between acetylcholine receptor and local anesthetic binding sites. Eur J Biochem. 94:1979;281-296.
69. Heidmann T., Oswald R.E., Changeux J.-P. Multiple sites of action of noncompetitive blockers on acetylcholine receptor rich membrane fragments from Torpedo marmorata. Biochemistry. 22:1983;3112-3127.
70. Arias H.R. Luminal and non-luminal non-competitive inhibitor binding sites on the nicotinic acetylcholine receptor. Mol Membr Biol. 13:1996;1-17.
71. Blanchard S.G., Elliot J., Raftery M.A. Interaction of local anesthetics with Torpedo californica membrane-bound acetylcholine receptor. Biochemistry. 18:1979;5880-5885.
72. 3H]perhydrohistrionicotoxin binding to Torpedo ocellata electroplax by effectors of the acetylcholine receptor. J Biol Chem. 256:1981;2843-2850.
73. Arias H.R., Alonso-Romanowski S., Disalvo E.A., Barrantes F.J. Interaction of merocyanine 540 with nicotinic acetylcholine receptor membranes from Discopyge tschudii electric organ. Biochim Biophys Acta. 1190:1994;393-401.
74. Lurtz M.M., Hareland M.L., Pedersen S.E. Quinacrine and ethidium bromide bind the same locus on the nicotinic acetylcholine receptor from Torpedo californica. Biochemistry. 36:1997;2068-2075.
75. Montal M., Montal M.S., Tomich J.M. Synporins-synthetic proteins that emulate the pore structure of biological ionic channels. Proc Natl Acad Sci USA. 87:1990;6929-6933.
76. Oblatt-Montal M., Bühler L.K., Iwamoto T., Tomich J.M., Montal M. Synthetic peptides and four-helix bundle proteins as model systems for the pore-forming structure of channel proteins. I. Transmembrane segment M2 of the nicotinic cholinergic receptor channel is a key pore-lining structure. J Biol Chem. 268:1993;14 601-14 607.
77. Oblatt-Montal M., Iwamoto T., Tomich J.M., Montal M. Design, synthesis and functional characterization of a pentameric channel protein that mimics the presumed pore structure of the nicotinic acetylcholine receptor. FEBS Lett. 320:1993;261-266.
78. Sine S.M., Taylor P. Local anesthetics and histrionicotoxin are allosteric inhibitors of the acetylcholine receptor. Studies of clonal muscle cells. J Biol Chem. 257:1982;8106-8114.
79. Blanton M.P., McCardy E., Gallaher T., Wang H.H. Noncompetitive inhibitors reach their binding site in the acetylcholine receptor by two different paths. Mol Pharmacol. 33:1988;634-642.
80. Earnest J.P., Limbacher H.P., McNamee M.G., Wang H.H. Binding of local anesthetics to reconstituted acetylcholine receptors: the effect of protein surface potential. Biochemistry. 25:1986;5809-5818.
81. Earnest J.P., Wang H.H., McNamee M.G. Multiple binding sites for local anesthetics on reconstituted acetylcholine receptor membranes. Biochem Biophys Res Commun. 123:1984;862-866.
82. Horváth L.I., Arias H.R., Hankovszky H.O., Hideg K., Barrantes F.J., Marsh D. Association of spin-labeled anesthetics at the hydrophobic surface of acetylcholine receptor in native membranes from Torpedo marmorata. Biochemistry. 29:1990;8707-8713.
83. Palma A., Herz J.M., Wang H.H., Taylor P. Association of spin-labeled local anesthetic with the allosterically coupled noncompetitive inhibitor site on the acetylcholine receptor. Mol Pharmacol. 30:1986;243-251.
84. Lin L., Koblin D.D., Wang H.H. Saturable binding of anesthetics to nicotinic acetylcholine receptors. A possible mechanism of anesthetic action. Ann NY Acad Sci. 625:1991;628-644.
85. Ellena J.F., Blazing M.A., McNamee M.G. Lipid-protein interactions in reconstituted membranes containing acetylcholine receptor. Biochemistry. 22:1983;5523-5535.
86. Arias H.R., Valenzuela F.C., Johnson D.A. Quinacrine and ethidium bind to different loci on the Torpedo acetylcholine receptor. Biochemistry. 32:1993;6237-6242.
87. Arias H.R. The high-affinity quinacrine binding site is located at a non-annular lipid domain of the nicotinic acetylcholine receptor. Biochim Biophys Acta. 1347:1997;9-22.
88. Arias H.R., Sankaram M.B., Marsh D., Barrantes F.J. Effect of local anaesthetics on steroid-nicotinic acetylcholine receptor interactions in native membranes of Torpedo marmorata electric organ. Biochim Biophys Acta. 1027:1990;287-294.
89. Chattopadhyay A., McNamee M.G. Average membrane penetration depth of tryptophan residues of the nicotinic acetylcholine receptor by the parallax method. Biochemistry. 30:1991;7159-7164.
90. Lehrer S.S. Solute perturbation of protein fluorescence. The quenching of the tryptophyl fluorescence of model compounds and of Lysozyme by iodide ions. Biochemistry. 10:1971;3254-3263.
91. Jones O.T., McNamee M.G. Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry. 27:1988;2364-2374.
92. Dreger M., Krauss M., Herrmann A., Hucho F. Interactions of the nicotinic acetylcholine receptor transmembrane segments with the lipid bilayer in native receptor-rich membranes. Biochemistry. 36:1997;839-847.
93. Arias H.R. Agonist-induced displacement of quinacrine from its binding site on the nicotinic acetylcholine receptor: plausible agonist membrane partitioning mechanism. Mol Membr Biol. 12:1995;339-347.
94. Narayanaswami V., Kim J., McNamee M.G. Protein-lipid interactions and Torpedo californica nicotinic acetylcholine receptor function. 1. Spatial disposition of cysteine residues in the γ subunit analyzed by fluorescence-quenching and energy-transfer measurements. Biochemistry. 32:1993;12 413-12 419.
95. González-Ros J.M., Farach M.C., Martínez-Carrión M. Ligand-induced effects at regions of acetylcholine receptor accessible to membrane lipids. Biochemistry. 22:1983;3807-3811.
96. Blanchard S.G., Raftery M.A. Identification of the polypeptide chains in Torpedo californica electroplax membranes that interact with a local anesthetic analog. Proc Natl Acad Sci USA. 76:1979;81-85.
97. Waksman G., Oswald R., Changeux J.P., Roques B. Synthesis and pharmacological activity on Electrophorus electricus electroplaque of photoaffinity labelling derivatives of noncompetitive blockers di- and tri-methisoquin. FEBS Lett. 111:1980;23-28.
98. 3H]-trimethisoquin azide of polypeptide chains present in acetylcholine receptor rich membranes from Torpedo marmorata. FEBS Lett. 111:1980;29-34.
99. 3H]trimethisoquin. FEBS Lett. 116:1980;30-36.
100. Oswald R.E., Changeux J.P. Selective labeling of the delta-subunit of the acetylcholine receptor by a covalent local anesthetic. Biochemistry. 20:1981;7166-7174.
101. Oswald R.E., Changeux J.P. Ultraviolet light-induced labelling by noncompetitive blockers of the acetylcholine receptor from Torpedo marmorata. Proc Natl Acad Sci USA. 78:1981;3925-3929.
102. Pedersen S.E., Dreyer E.B., Cohen J.B. Location of ligand-binding sites on the nicotinic acetylcholine receptor α-subunit. J Biol Chem. 261:1986;13 735-13 743.
103. 3H]meproadifen mustard with membrane-bound Torpedo acetylcholine receptor. J Biol Chem. 261:1986;13 727-13 734.
104. 3H]Meproadifen mustard reacts selectively with α-subunit Glu-262. J Biol Chem. 267:1992;10 489-10 499.
105. Galzi J.L., Revah R., Bouet F., Ménez A., Goeldner M., Hirth C., Changeux J.P. Allosteric transitions of the acetylcholine receptor probed at the amino acid level with a photolabile cholinergic ligand. Proc Natl Acad Sci USA. 88:1991;5051-5055.
106. Ohno K., Hutchinson D.O., Milone M., Brengman J.M., Bouzat C., Sine S.M., Engel A.G. Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel opening due to a mutation in the M2 domain of the ε subunit. Proc Natl Acad Sci USA. 92:1995;758-762.
107. Bouzat C., Barrantes F.J. Modulation of muscle nicotinic acetylcholine receptors by the glucocorticoid hydrocortisone, possible allosteric mechanism of channel blockade. J Biol Chem. 271:1996;25 835-25 841.
108. Bouzat C., Bren N., Sine S.M. Structural basis of the different gating kinetics of fetal and adult acetylcholine receptors. Neuron. 13:1994;1395-1402.
109. Murray N., Zheng Y.C., Mandel G., Brehm P., Bolinger R., Reuer Q., Kullberg R. A single site on the ε subunit is responsible for the change in ACh receptor channel conductance during skeletal muscle development. Neuron. 14:1995;865-870.
110. Stallcup W.B., Patrick J. Substance P enhances cholinergic receptor desensitization in a clonal nerve cell line. Proc Natl Acad Sci USA. 77:1980;634-638.
111. Galzi J.L., Bertrand D., Devillers-Thiéry A., Revah F., Bertrand S., Changeux J.P. Functional significance of aromatic amino acids from three peptide loops of the α7 neuronal nicotinic acetylcholine receptor. Site investigated by site-directed mutagenesis, FEBS Lett. 294:1991;198-202.
112. Ortells M.O., Lunt G.G. The transmembrane region of the nicotinic acetylcholine receptor: is it an all-helix bundle? Recept Chann. 2:1994;53-59.
113. Pascual J.M., Karlin A. Binding site for QX-314, a quaternary lidocaine derivative, in the channel of the acetylcholine receptor. Biophys J. 72:1997;A151.
114. Pascual J.M., Karlin A. State-dependent accessibility and electrostatic potential in the channel of the actylcholine receptor. Inferences from rates of reaction of thiosulfonates with substituted cysteines in the M2 segment of the α subunit. J Gen Physiol. 111:1998;717-739.
115. Wilson G.G., Karlin A. The location of the gate in the acetylcholine receptor channel. Neuron. 20:1998;1269-1281.
116. Moore A.M., McCarthy M.P. The effects of drugs on the incorporation of a conformationally-sensitive, hydrophobic probe into the ion channel of the nicotinic acetylcholine receptor. Biochim Biophys Acta. 1190:1994;457-464.
117. 22Na+ ion fluxes. Biochemistry. 23:1984;4023-4033.
118. 3H]-tetracaine to the Torpedo nicotinic acetylcholine receptor. Biophys J. 66:1994;A425.
119. Li L., Lee Y.H., Pappone P., Palma A., McNamee M.G. Site-specific mutations of nicotinic acetylcholine receptor at the lipid-protein interface dramatically alter ion channel gating. Biophys J. 62:1992;61-63.
120. Johnson D.A., Ayres S., Woltman W. Simultaneous binding of two different noncompetitive inhibitors to the open-channel configuration of the nicotinic acetylcholine receptor. Biophys J. 72:1997;A152.
121. Johnson D.A., Nuss J.M. The histrionicotoxin-sensitive ethidium binding site is located outside of the transmembrane domain of the nicotinic acetylcholine receptor: a fluorescence study. Biochemistry. 33:1994;9070-9077.
122. Blickenstaff G.D., Wang H.H. The effects of spin labeled local anesthetics on acetylcholine receptor-mediated ion flux. Biophys J. 47:1985;261a.
123. Bonini I.C., Aveldaño M.I., Barrantes F.J. Asymmetric distribution of phospholipids in acetylcholine receptor-rich membranes from T. marmorata electric organ. Int J Biochem. 22:1990;785-789.
124. Hann R.M., Evans J.E., McCluer R.H., Eterovic V.A. Gangliosides in membranes from Torpedo electric organ. Lipids. 31:1996;627-633.
125. Marcheselli V., Daniotti J.L., Vidal A.C., Maccioni H., Marsh D., Barrantes F.J. Gangliosides in acetylcholine receptor-rich membranes from Torpedo marmorata and Discopyge tschudii. Neurochem Int. 18:1993;599-603.
126. Miyazaki J., Hideg K., Marsh D. Interfacial ionization and partitioning of membrane-bound local anaesthetics. Biochim Biophys Acta. 1103:1992;62-68.
127. Andreasen T.J., McNamee M.G. Inhibition of ion permeability control properties of acetylcholine receptor from Torpedo californica by long-chain fatty acids. Biochemistry. 19:1980;4719-4726.
128. Arias H.R. Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules. J Neurosci Res. 52:1998;369-379.
129. Arias H.R. Temperature and ionic strength dependence of quinacrine binding and quinacrine displacement elicited by high concentrations of agonists on the nicotinic acetylcholine receptor. Arch Biochem Biophys. 333:1996;1-11.
130. Herz J.M., Kolb S.J., Erlinger T., Schmid E. Channel permeant cations compete selectively with noncompetitive inhibitors of the acetylcholine receptor. J Biol Chem. 266:1992;16 691-16 698.
131. 3H]α-toxin to membrane fragments from Electrophorus and Torpedo electric organs. Mol Pharamcol. 10:1974;35-40.
132. Boess F.G., Steward L.J., Steele J.A., Liu D., Reid J., Glencorse T.A., Martin I.L. Analysis of the ligand binding site of the 5-HT3 receptor using site directed mutagenesis: importance of glutamate 106. Neuropharmacology. 36:1997;637-647.
133. Schulte M., Bloom K.E., White M.M. Evidence for the involvement of tryptophan in the binding of curare to 5-HT3 receptors. Soc Neurosci Abst. 21:1995;306.
134. Gurley D.A., Lanthorn T.H. Nicotinic agonists competitively antagonize serotonin at mouse 5-HT3 receptors expressed in Xenopus oocytes. Neurosci Lett. 247:1998;107-110.
135. Newberry N.R., Cheshire S.H., Gilbert M.J. Evidence that the 5-HT3 receptors of the rat, mouse and guinea-pig superior cervical ganglion may be different. Br J Pharmacol. 102:1991;615-620.
136. Winter J.T.V., Stickler D.B. Panic attack syndrome. J Pediatr. 105:1984;661-665.
137. Woolverton W.L., Balster R.L. Reinforcing properties of some local anestetics in Rhesus monkeys. Pharmacol Biochem Behav. 11:1979;669-672.
138. Zacny J.P., Woolverton W.L. Discriminative stimulus properties of local anesthetics in d-amphetamine- and pentobarbital-trained pigeons. Pharmacol Biochem Behav. 33:1989;527-531.
139. Van Dyke C., Jatlow P., Ungerer J., Barash P., Ryck R. Cocaine and lidocaine have similar psychological effects after intranasal applications. Life Sci. 24:1979;271-274.
140. Volkow N.D., Fowler J.S., Wolf A.P. Use of positron emission tomography to study cocaine in the human brain. Rapaka R., Makriyannis A., Kuhar M.J. NIDA Research Monograph. 112:1991;168-179 NIDA, Rockville, MD.
141. Williams M., Arneric S. Beyond the tobacco debate: Dissecting out the therapeutic potential of nicotine. Exp Opin Invest Drugs. 5:1996;1035-1045.
142. Gage P.W., Hamill O.P., Wachtel R.E. Sites of action of procaine at the motor end-plate. J Physiol. 335:1983;123-137.
143. Weiland G., Georgia B., Lappi S., Chignell C.F., Taylor P. Kinetics of agonist-mediated transitions in state of the cholinergic receptor. J Biol Chem. 252:1977;7648-7656.
144. Oswald R.E. Binding of phencyclidine to the detergent solubilized acetylcholine receptor from Torpedo marmorata. Life Sci. 32:1983;1143-1149.
145. Eterovic V.A., Li L., Ferchmin P.A., Lee Y.H., Hann R.M., Rodriguez A.D., McNamee M.G. The ion channel of muscle and electric organ acetylcholine receptors: differeing affinities for noncompetitive inhibitors. Cell Mol Neurobiol. 13:1993;111-121.
146. Herz J.M., Johnson D.A., Taylor P. Interaction of noncompetitive inhibitors with the acetylcholine receptor. The site specificity and spectroscopic properties of ethidium binding. J Biol Chem. 262:1987;7238-7247.
147. Weiland G.A., Durkin J.A., Henley J.M., Simasko S.M. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors. Mol Pharmacol. 32:1987;625-632.
148. Neubig R.R., Krodel E.K., Boyd N.D., Cohen J.B. Acetylcholine and local anesthetic binding to Torpedo nicotinic postsynaptic membranes after removal of nonreceptor peptides. Proc Natl Acad Sci USA. 76:1979;690-694.
149. Sobel A., Heidmann T., Cartaud J., Changeux J.P. Reconstitution of a functional acetylcholine receptor. Polypeptide chains, ultrastructure and binding sites for acetylcholine and local anesthetics. Eur J Biochem. 110:1980;13-33.
150. Krodel E.K., Beckman R.A., Cohen J.B. Identification of a local anesthetic binding site in nicotinic post-synaptic membranes isolated from Torpedo marmorata electric tissue. Mol Pharmacol. 15:1979;294-312.
151. Limbacher H.P., Blickenstaff G.D., Bowen J.H., Wang H.H. Multiequilibrium binding of a spin-labeled local anesthetic in phosphatidylcholine bilayers. Biochim Biophys Acta. 812:1985;268-276.